Bone, heal thyself

Lee, Andrew
July 2002
Engineer (00137758);7/5/2002, Vol. 291 Issue 7607, p14
Focuses on the benefits on injected bio-compatible cement directly into the backbone for the treatment of damaged spines developed by physician Ruth Wilcox at Leeds University in England. Use of percutaneous vertebrosplasty; Benefits of injected cement; Award given to Wilcox by the Royal Academy of Engineering.


Related Articles

  • Cement gives hope to brittle tone.  // Professional Engineering;6/26/2002, Vol. 15 Issue 12, p55 

    Focuses on mechanical engineer Ruth Wilcox's work which aims to optimize a technique called percutaneous vertebroplasty (PVP). Treatment of vertebral compression fractures in old people suffering from osteoporosis; Injection of a special bone cement into the vertebrae of the spine to stabilize...

  • Screening for osteoporosis gets easier.  // Tufts University Health & Nutrition Letter;Jun98, Vol. 16 Issue 4, p1 

    Presents information on a bone-scanning device called the Sahara to detect osteoporosis. How the disease is detected; Who approved the device; Functions of the device; Expected cost for the Sahara test; Comments from Bess Dawson-Hughes, chief of the Calcium and Bone Metabolism Laboratory at Tufts.

  • Does calcium build bone mass in postmenopausal women?  // Executive Health's Good Health Report;Dec93, Vol. 30 Issue 3, p8 

    Renders the results of a study on calcium supplements intake to combat bone tissue loss leading to osteoporosis. Increased calcium intake as not improving bone density; Little effect of extra vitamin D intake and doing weight-bearing exercises; Estrogen replacement therapy for bone maintenance;...

  • Osteoporosis drugs: How effective?  // HealthFacts;Feb96, Vol. 21 Issue 201, p3 

    Reports that the drugs Fosamax and Miacalcin have been approved for the treatment of postmenopausal osteoporosis, which is a bone-thinning disease that leads to fractures. Information on the drugs; Other drugs for the treatment of osteoporosis; Statistics from studies compared Miacalcin with...

  • The two new options for osteoporosis.  // Modern Medicine;Jan96, Vol. 64 Issue 1, p24 

    Discusses the options for treating osteoporosis. Effectiveness of using the non-hormonal alendronate; Use of the intranasal calcitonin-salmon; Recommended dosage; Side effects.

  • New cautions for osteoporosis drug.  // Modern Medicine;Jun96, Vol. 64 Issue 6, p41 

    Reports that the labeling for alendronate sodium has been revised as a precaution for patients taking it for osteoporosis. Warning against patients with abnormalities of the esophagus.

  • Simple brace improves back strength in women with osteoporosis.  // Modern Medicine;Jun96, Vol. 64 Issue 6, p46 

    Presents the abstract of the study entitled `Effect of Back Supports on Back Strength in Patients with Osteoporosis: A Pilot Study,' by Kaplan, Sinaki et al published in the March 1996 issue of the `Mayo Clin Proc' periodical concerning the treatment of osteoporosis.

  • An alternative to replacing estrogen.  // USA Today Magazine;Oct95, Vol. 124 Issue 2605, p14 

    Reports on testing of the drug raloxifene at the Indiana-Purdue University at Indianapolis which could prevent bone loss and offer an alternative to estrogen replacement for post-menopausal women. Negative effects of estrogen replacement; Drug's role in lowering the risk of heart disease.

  • Osteoporosis: Drug and nondrug therapies for the patient at risk. Gamble, Cory L. // Geriatrics;Aug95, Vol. 50 Issue 8, p39 

    Discusses drug and nondrug therapies for treating patients at risk for osteoporosis. Exercises, calcium intake and prevention of falls as measures included in nondrug therapies; Protection provided by estrogen replacement therapy; Calcitonin as an option upon contraindication of estrogen.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics